CareDx Free Cash Flow 2013-2023 | CDNA
CareDx free cash flow from 2013 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| CareDx Annual Free Cash Flow | |
|---|---|
| 2023 | -26.73 |
| 2022 | -46.47 |
| 2021 | -32.85 |
| 2020 | 26.32 |
| 2019 | -4.97 |
| 2018 | -6.04 |
| 2017 | -14.49 |
| 2016 | -17.07 |
| 2015 | -10.95 |
| 2014 | -4.08 |
| 2013 | -0.64 |
| 2012 | -1.92 |
| CareDx Quarterly Free Cash Flow | |
|---|---|
| 2023-12-31 | -26.73 |
| 2023-09-30 | -16.76 |
| 2023-06-30 | -4.96 |
| 2023-03-31 | -2.10 |
| 2022-12-31 | -46.47 |
| 2022-09-30 | -50.38 |
| 2022-06-30 | -38.46 |
| 2022-03-31 | -29.93 |
| 2021-12-31 | -32.85 |
| 2021-09-30 | -31.17 |
| 2021-06-30 | -27.93 |
| 2021-03-31 | -34.88 |
| 2020-12-31 | 26.32 |
| 2020-09-30 | 19.58 |
| 2020-06-30 | 17.61 |
| 2020-03-31 | -4.76 |
| 2019-12-31 | -4.97 |
| 2019-09-30 | -2.66 |
| 2019-06-30 | -2.85 |
| 2019-03-31 | -6.41 |
| 2018-12-31 | -6.04 |
| 2018-09-30 | -7.08 |
| 2018-06-30 | -6.87 |
| 2018-03-31 | -4.58 |
| 2017-12-31 | -14.49 |
| 2017-09-30 | -12.26 |
| 2017-06-30 | -10.03 |
| 2017-03-31 | -6.81 |
| 2016-12-31 | -17.07 |
| 2016-09-30 | -14.09 |
| 2016-06-30 | -12.54 |
| 2016-03-31 | -6.30 |
| 2015-12-31 | -10.95 |
| 2015-09-30 | -6.90 |
| 2015-06-30 | -3.48 |
| 2015-03-31 | -1.38 |
| 2014-12-31 | -4.08 |
| 2014-09-30 | -2.96 |
| 2014-06-30 | 0.87 |
| 2014-03-31 | 0.16 |
| 2013-12-31 | -0.64 |
| 2013-09-30 | 0.31 |
| 2013-06-30 | -1.31 |
| 2013-03-31 | -0.93 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.794B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.258B | 15.59 |
| Cencora (COR) | United States | $44.266B | 17.26 |
| ICON (ICLR) | Ireland | $26.033B | 24.58 |
| DiDi Global (DIDIY) | China | $23.379B | 0.00 |
| Avantor (AVTR) | United States | $17.056B | 25.11 |
| CochLear (CHEOY) | Australia | $14.191B | 0.00 |
| Viatris (VTRS) | United States | $13.264B | 3.96 |
| Revvity (RVTY) | United States | $13.145B | 23.06 |
| Natera (NTRA) | United States | $12.958B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.348B | 40.62 |
| Charles River Laboratories (CRL) | United States | $11.993B | 22.96 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.923B | 0.00 |
| Solventum (SOLV) | United States | $11.243B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.782B | 0.00 |
| HealthEquity (HQY) | United States | $6.591B | 49.24 |
| Organon (OGN) | United States | $5.491B | 5.21 |
| Bausch + Lomb (BLCO) | Canada | $5.234B | 20.97 |
| Doximity (DOCS) | United States | $4.386B | 32.65 |
| PACS (PACS) | United States | $4.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.426B | 31.35 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Life Times (LTH) | United States | $2.939B | 30.79 |
| GoodRx Holdings (GDRX) | United States | $2.627B | 95.00 |
| Progyny (PGNY) | United States | $2.617B | 45.05 |
| AMN Healthcare Services Inc (AMN) | United States | $2.370B | 9.39 |
| Premier (PINC) | United States | $2.365B | 8.85 |
| Agilon Health (AGL) | United States | $2.262B | 0.00 |
| NovoCure (NVCR) | Jersey | $2.187B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.161B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.936B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.618B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.338B | 0.00 |
| Embecta (EMBC) | United States | $0.842B | 5.73 |
| Pediatrix Medical (MD) | United States | $0.714B | 7.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.453B | 45.20 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| ModivCare (MODV) | United States | $0.384B | 7.18 |
| MultiPlan (MPLN) | United States | $0.364B | 0.00 |
| Beauty Health (SKIN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.344B | 18.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.281B | 0.00 |
| Sharecare (SHCR) | United States | $0.273B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.271B | 0.00 |
| Biodesix (BDSX) | United States | $0.171B | 0.00 |
| So-Young (SY) | China | $0.126B | 42.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.77 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |